Asi Haviv

Safety and Efficacy of Oral Octreotide in Acromegaly: Results of a Multicenter Phase III Trial

Vera Popović, Martin Bidlingmaier, Moisés Mercado et al. · The Journal of Clinical Endocrinology & Metabolism · 2015 · 169 citations · Full text

Maintenance of Acromegaly Control in Patients Switching From Injectable Somatostatin Receptor Ligands to Oral Octreotide

Susan L. Samson, Lisa B. Nachtigall, Maria Fleseriu et al. · The Journal of Clinical Endocrinology & Metabolism · 2020 · 96 citations · Full text

A phase II study of laquinimod in Crohn's disease

Geert D’Haens, William J. Sandborn, Jean‐Frédéric Colombel et al. · Gut · 2014 · 79 citations · Full text

Patient-reported outcomes of parenteral somatostatin analogue injections in 195 patients with acromegaly

Christian J. Strasburger, Niki Karavitaki, Sylvère Störmann et al. · European Journal of Endocrinology · 2015 · 74 citations · Full text

Maintenance of response to oral octreotide compared with injectable somatostatin receptor ligands in patients with acromegaly: a phase 3, multicentre, randomised controlled trial

Maria Fleseriu, Alexander Dreval, Irina Bondar et al. · The Lancet Diabetes & Endocrinology · 2021 · 49 citations · Full text

Allergy, Injectable Somatostatin Receptor, Clinical Trials +3